DUBLIN, Jan. 24, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that the peer-reviewed Journal of Hand Surgery Global Open published Collagenase Clostridium Histolyticum for ...
Common activities for patients with Dupuytren's such as those at the workplace (eg, manual labor, wearing gloves) or at home (eg, washing, dressing) can be signicantly affected, posing a threat to ...
MALVERN, Pa., Nov. 20, 2024 /CNW/ -- Endo, Inc. ("Endo") (OTCQX: NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his treatment ...
If you have Dupuytren’s contracture or Peyronie’s disease, your doctor may suggest treatment with Xiaflex. This is a prescription medication used to treat these two conditions in adults in certain ...
Xiaflex (collagenase clostridium histolyticum) is a brand-name injection that’s prescribed for Peyronie’s disease and Dupuytren’s contracture in adults. As with other drugs, Xiaflex can cause side ...
The U.S. Food and Drug Administration today approved a new use for Xiaflex (collagenase clostridium histolyticum) as the first FDA-approved medicine to treat men with bothersome curvature of the penis ...
DUBLIN, June 5, 2023 /PRNewswire/ -- Endo International plc (ENDPQ) announced today that post-hoc data from two Phase 3 studies of XIAFLEX ® (collagenase clostridium histolyticum, or CCH, injection ...
The incidence of surgical intervention in veterans treated with Collagenase clostridium histolyticum
Peyronie’s disease (PD) can be managed with surgery or intralesional injections of Collagenase clostridium histolyticum (CCH) however both are associated with side effects and variable results. It is ...
Consensus-based study findings among expert hand surgeons indicate that XIAFLEX ® (collagenase clostridium histolyticum) has a wide-ranging application for the appropriate treatment of Dupuytren's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results